[1]
2015. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers . Brazilian Journal of Pharmaceutical Sciences. 51, 1 (Mar. 2015), 203–211. DOI:https://doi.org/10.1590/S1984-82502015000100020.